Evidence map›Paper›PMID 22290960›Full record

ArticleAntimicrobial agents and chemotherapy2012

IMP-29, a novel IMP-type metallo-β-lactamase in Pseudomonas aeruginosa.

Katy Jeannot, Laurent Poirel, Marjorie Robert-Nicoud, Pascal Cholley, Patrice Nordmann, Patrick Plésiat

Abstract readCase Reports
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Katy JeannotCentre National de la Résistance aux Antibiotiques, Laboratoire associé Pseudomonas aeruginosa, Hôpital Jean Minjoz, Besançon, France.
Laurent Poirel
Marjorie Robert-Nicoud
Pascal Cholley
Patrice Nordmann
Patrick Plésiat

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Analysis of two clonally related multiresistant Pseudomonas aeruginosa isolates led to the identification of a novel IMP-type metallo-β-lactamase. IMP-29 was significantly different from the other IMP variants (the closest variant being IMP-5 with 93% amino acid identity). The bla(IMP-29) gene cassette was carried by a class 1 integron in strain 10.298, while in strain 10.266 it was located in a rearranged DNA region on a 30-kb conjugative plasmid. Biochemical analysis confirmed that IMP-29 efficiently hydrolyzed carbapenems.

Indexed as

AgedAnti-Bacterial Agentsbeta-LactamasesCarbapenemsDNA, BacterialEscherichia coliFatal OutcomeHumansHydrolysisIntegronsMaleMicrobial Sensitivity TestsPolymerase Chain ReactionPseudomonas aeruginosaPseudomonas InfectionsShock, SepticAnti-Bacterial Agentsbeta lactamase IMP-29, Pseudomonas aeruginosabeta-LactamasesCarbapenemsDNA, Bacterial

Identifiers

PMID22290960
PMCPMC3318365

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.